- Home
- AXSM vs BRFS Comparison
AXSM vs BRFS Comparison
Compare AXSM & BRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- BRFS
- Stock Information
- Founded
- AXSM 2012
- BRFS 1934
- Country
- AXSM United States
- BRFS Brazil
- Employees
- AXSM N/A
- BRFS N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- BRFS Meat/Poultry/Fish
- Sector
- AXSM Health Care
- BRFS Consumer Staples
- Exchange
- AXSM Nasdaq
- BRFS Nasdaq
- Market Cap
- AXSM 5.1B
- BRFS 5.6B
- IPO Year
- AXSM 2015
- BRFS 2000
- Fundamental
- Price
- AXSM $108.98
- BRFS $3.91
- Analyst Decision
- AXSM Strong Buy
- BRFS Hold
- Analyst Count
- AXSM 17
- BRFS 2
- Target Price
- AXSM $171.65
- BRFS $13.75
- AVG Volume (30 Days)
- AXSM 636.2K
- BRFS 5.9M
- Earning Date
- AXSM 08-04-2025
- BRFS 08-13-2025
- Dividend Yield
- AXSM N/A
- BRFS 2.24%
- EPS Growth
- AXSM N/A
- BRFS N/A
- EPS
- AXSM N/A
- BRFS 0.41
- Revenue
- AXSM $432,157,000.00
- BRFS $11,077,622,712.00
- Revenue This Year
- AXSM $62.84
- BRFS $11.01
- Revenue Next Year
- AXSM $60.02
- BRFS $4.38
- P/E Ratio
- AXSM N/A
- BRFS $9.91
- Revenue Growth
- AXSM 72.16
- BRFS 18.02
- 52 Week Low
- AXSM $72.21
- BRFS $2.99
- 52 Week High
- AXSM $139.13
- BRFS $4.87
- Technical
- Relative Strength Index (RSI)
- AXSM 56.00
- BRFS 57.17
- Support Level
- AXSM $102.26
- BRFS $3.84
- Resistance Level
- AXSM $114.66
- BRFS $4.09
- Average True Range (ATR)
- AXSM 3.49
- BRFS 0.14
- MACD
- AXSM 0.92
- BRFS 0.04
- Stochastic Oscillator
- AXSM 61.89
- BRFS 68.10
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About BRFS BRF S.A.
BRF SA is an international producer of fresh and frozen protein foods. It operates by raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, pet food, and others. The Company holds as its main brands Sadia, Perdigao, Qualy, Chester, Kidelli, Perdix, Banvit, Biofresh, and Gran Plus, present mainly in Brazil, Turkey, and Middle Eastern countries. The group has three reportable segments, being; Brazil, International, and Other segments.